Published on in Vol 6, No 3 (2017): March
![Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal Cancer Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal Cancer](https://asset.jmir.pub/assets/a135f5020e102e5d456c73e9be486cbd.jpeg 480w,https://asset.jmir.pub/assets/a135f5020e102e5d456c73e9be486cbd.jpeg 960w,https://asset.jmir.pub/assets/a135f5020e102e5d456c73e9be486cbd.jpeg 1920w,https://asset.jmir.pub/assets/a135f5020e102e5d456c73e9be486cbd.jpeg 2500w)
1 Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom
2 NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia
3 Oncology Clinical Trials Office, Department of Oncology, University of Oxford, Oxford, United Kingdom
4 Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom
5 University of Western Australia, Perth, Australia
6 Western Hospital, Footscray, Victoria, Australia
7 National Institute for Health Research University College London Hospitals Biomedical Research Centre, London, United Kingdom
8 Cancer Research United Kingdom–Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom